Shandong Weigao Group Medical Polymer Company Limited has announced that its board of directors will convene on 27 March 2026. The purpose of the meeting is to consider and approve the audited annual results for the financial year ended 31 December 2025, as well as to discuss the possible distribution of a final dividend. The announcement, dated 3 March 2026, also lists the members of the board of directors, chaired by Long Jing, and confirms that the meeting will be held in Weihai, Shandong, in the People’s Republic of China.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments